News

GCU Holds Webinar On Coronavirus Vaccine and Related Myths

LinkedIn

LAHORE: A webinar on “Coronavirus vaccine and myths related to it” was held at the Government College University Lahore under the auspices of its Disease Awareness and Prevention Society.

The two-hour webinar, addressed by the renowned infectious diseases and internal medicine expert  Dr. Faheem Younus and Vice Chancellor Prof. Dr. Asghar Zaidi aimed at diminishing misconceptions regarding the coronavirus and its vaccines.

The medicine expert provided updated and authentic information to the university students regarding its future prospects in Pakistan.

Addressing the webinar via zoom Dr. Younus said that two successful RNA-based vaccines (Pfizer and Moderna) would be soon available in the global biotech market for all countries and explained their mode of operation.

He added that these vaccines identify the spike proteins and then synthesize mRNA products, which after giving signals to the body, self-destructs and dissolves in the system.

With this exploratory analysis, Dr. Younas tried to bust the myth of lasting side effects.  He expressed Pakistan would be able to prioritize and systematically distribute the vaccine, upon its reception, first among its front line workers, then among older people and finally the youth.

“Vaccines may cause minimal side effects in some people but would overall be beneficial,” Dr Younas said.

Vice Chancellor Prof. Zaidi enlightened the participants and the fellow panellists about the importance of vaccines especially to the older people which have been the focal point of his research endeavours.

GCU VC also apprised the audience regarding the  initiatives by GCU Lahore in these difficult and demanding times to raise awareness about coronavirus and practically support the frontline health workers.

 

There are no reviews yet.

Be the first to review “GCU Holds Webinar On Coronavirus Vaccine and Related Myths”

Your email address will not be published.

Student Experience
Campus Infrastrucure
Faculty